CASE REPORT
Hypereosinophilia in an infant – case report. The role of eosinophils in selected diseases
 
More details
Hide details
1
Department of Paediatrics, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Zabrze, Poland
 
2
Department of Paediatric Haematology and Oncology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Zabrze, Poland
 
 
Submission date: 2019-06-17
 
 
Final revision date: 2019-07-31
 
 
Acceptance date: 2019-08-02
 
 
Publication date: 2019-08-30
 
 
Pediatr Pol 2019;94(4):266-270
 
KEYWORDS
TOPICS
ABSTRACT
Eosinophilia is a condition in which the number of eosinophils in the peripheral blood or tissues increases above the normal level. Threshold values for eosinophilia change with age, remaining the highest in infants and young children. Hypereosinophilia is rare and requires detailed diagnosis. The causes of eosinophilia vary. The literature distinguishes its primary form – associated with bone marrow proliferative diseases, and the condition secondary to many diseases, most commonly parasitic infections and allergic reactions. The secondary form of eosinophilia is most frequent in children. Chronic activation of eosinophils can lead to fibrosis and thrombotic changes in tissues affected by infiltration. In the paediatric population, contrary to adults, these pathological processes are more common in the gastrointestinal tract. Hypereosinophilia is rare in infants, which favours diagnostic and therapeutic concerns. In this paper, we present a case of a 10-month-old infant with hypereosinophilia coexisting with lambliosis and food intolerance.
REFERENCES (31)
1.
Wang SA. The Diagnostic Work-Up of Hypereosinophilia. Pathobiol 2019; 86: 39-52.
 
2.
Schwartz JT, Fulkerson PC. An Approach to the Evaluation of Persistent Hypereosinophilia in Pediatric Patients. Front Immunol 2018; 9: 1944.
 
3.
Gotlib J. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification and management. Am J Hematol 2017; 92: 1243-1259.
 
4.
Montgomery ND, Dunphy CH, Mooberry M, et al. Diagnostic Complexities of Eosinophilia. Arch Pathol Lab Med 2013; 137: 259-269.
 
5.
Williams KW, Ware JA, Abiodun A, et al. Hypereosinophilia in children and adults: a retrospective comparison. J Allergy Clin Immunol Pr 2016; 4: 941-947.
 
6.
Navabi B, Upton JE. Primary immunodeficiencies associated with eosinophilia. Allergy Asthma Clin Immunol 2016; 12: 27.
 
7.
Williams KW, Milner JD, Freeman AF. Eosinophilia Associated with Disorders of Immune Deficiency or Immune Dysregulation. Immunol Allergy Clin North Am 2015; 35: 523-544.
 
8.
Mukherjee M, Lacy P, Ueki S. Eosinophil Extracellular Traps and Inflammatory Pathologies – Untangling the Web! Front Immunol 2018; 9: 2763.
 
9.
Matoszka N, Działo J, Tokarz-Deptuła B, Deptuła W. NET and NETosis – new phenomenon in immunology. Postep Hig Med Dosw 2012; 66: 437-445.
 
10.
Akuthota P, Weller PF. Eosinophils and Disease Pathogenesis. Semin Hematol 2013; 49: 113-119.
 
11.
Bałajewicz-Nowak M, Glanowska I, Hosiawa W, et al. Wodobrzusze w przebiegu hipereozynofilii – opis przypadku i przegląd piśmiennictwa. Curr Gynecol Oncol 2018; 16: 57-63.
 
12.
Cotton JA, Beatty JK, Buret AG. Host parasite interactions and pathophysiology in Giardia infections. Int J Parasitol 2011; 41: 925-933.
 
13.
Ahmad RN, Sherjil A, Mahmood A, et al. Severe eosinophilia in a case of giardiasis. Mediterr J Hematol Infect Dis 2011; 3: e2011009.
 
14.
Suzuki Y, Nakamura T, Tokoro M, et al. A case of giardiasis expressing severe systemic symptoms and marked hypereosinophilia. Parasitol Int 2010; 59: 487-489.
 
15.
Lakshman A, Nampoothiri RV, Law AD, et al. Hypereosinophilia in a Young Patient: Occam’s Razor or Hickam’s Dictum? Indian J Hematol Blood Transfus 2016; 32 (Suppl 1): 340-343.
 
16.
Rogawski ET, Bartelt LA, Platts-Mills JA, et al. Determinants and Impact of Giardia Infection in the First 2 Years of Life in the MAL-ED Birth Cohort. J Pediatric Infect Dis Soc 2017; 6: 153-160.
 
17.
Kubiak K, Dzika E, Dobrzańska M, et al. Giardiasis in the Warmia and Mazury province (north-eastern Poland) – an epidemiological analysis. Polish Ann Med 2017; 24: 5-8.
 
18.
Halliez MCM, Buret AG. Extra-intestinal and long term consequences of Giardia duodenalis infections. World J Gastroenterol 2013; 19: 8974-8985.
 
19.
Minetti C, Chalmers RM, Beeching NJ, et al. Giardiasis. BMJ 2016; 355i5369.
 
20.
Czarkowski MP, Cielebąk E, Staszewska-Jakubik E, Kondej B. Choroby zakaźne i zatrucia w Polsce w 2017 roku. Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny Zakład Epidemiologii Chorób Zakaźnych i Nadzoru, Warszawa 2018.
 
21.
Cernikova L, Faso C, Hehl AB. Five facts about Giardia lamblia. PLoS Pathog 2018; 14: e1007250.
 
22.
Gardner TB, Hill DR. Treatment of Giardiasis. Clin Microbiol Rev 2001; 14: 114-128.
 
23.
Guarino A, Ashkenazi S, Gendrel D, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr 2014; 59: 132-152.
 
24.
Soares R, Tasca T. Giardiasis: an update review on sensitivity and specificity of methods for laboratorial diagnosis. J Microbiol Methods 2016; 129: 98-102.
 
25.
Adeyemo FE, Singh G, Reddy P, Stenström TA. Methods for the detection of Cryptosporidium and Giardia: From microscopy to nucleic acid based tools in clinical and environmental regimes. Acta Trop 2018; 184: 15-28.
 
26.
Charakterystyka produktu leczniczego Metronidazol. 07.06.2018 r.
 
27.
Jeske J, Malinowska B, Kamerys J, et al. Effectiveness of azithromycin in the treatment of giardiasis. Med Sci Monit 1998; 4: 547-550.
 
28.
Beer KD, Collier SA, Du F, Gargano JW. Giardiasis Diagnosis and Treatment Practices Among Commercially Insured Persons in the United States. Clin Infect Dis 2017; 64: 1244-1250.
 
29.
Ho MH, Wong WH, Chang C. Clinical spectrum of food allergies: a comprehensive review. Clin Rev Allergy Immunol 2014; 46: 225-240.
 
30.
Yamada Y, Nishi A, Ebara Y, et al. Eosinophilic Gastrointestinal Disorders in Infants: A Japanese Case Series. Int Arch Allergy Immunol 2011; 155 (Suppl 1): 40-45.
 
31.
Rogowska A. [Eosinophilic gastrointestinal disorders]. Gastroenterol Klin 2012; 4: 105-116.
 
Journals System - logo
Scroll to top